title: Hypogonadotrophic hypogonadism associated with prelingual deafness due to a connexin 26 gene mutation.
abstract: In Mediterranean countries, almost half the incidence of non-syndromic congenital hearing loss is caused by mutations in the gap junction (GJ) connexin 26 gene (GJB2/DFNB1 locus). In this form of deafness the cochlear defect is usually isolated. We describe here the first case of hypogonadotrophic hypogonadism in association with this particular cochlear defect. The male patient had moderate deafness inherited from his deaf parents. All family members had a homozygous 35delG mutation in the connexin 26 gene. This mutation accounts for 70% of all connexin 26 gene mutations. The patient was referred to a paediatric endocrinology unit at 11 years of age for moderate growth retardation. Growth rate was normal until 11 years. The patient then presented delayed puberty (testicular volume 4 ml, penis length 4 cm) and did not undergo the usual pubertal growth spurt. LH and FSH secretory responses to GnRH at the age of 14.5 years (bone age 13.5 years), were: LH baseline level 1.1 IU/l, peak 34 IU/l; FSH baseline level 1.8 IU/l, peak 5.7 IU/l. Testosterone concentration was <0.11 ng/ml. From 11 to 14 years old, testosterone concentration ranged from 0.11 to 0.2 ng/ml. Anti-Mullerian hormone (AMH) level was 38.6 ng/ml (normal for Tanner stage I), cortisol 109 ng/ml, and ACTH 37 pg/ml., Karyotype was 46 XY. On MRI analysis, the anterior pituitary and olfactory bulbs were normal. These data were consistent with partial hypogonadotrophic hypogonadism of hypothalamic origin, and the patient was treated with testosterone. This report supports the possible involvement of connexins in puberty initiation. Connexins may play a part in the co-ordination and synchronisation of GnRH release.
authors.affiliation: Laboratoire d'Explorations Fonctionnelles Endocriniennes, Hĵpital d'Enfants Armand Trousseau, Paris, France. lab.endo@trs.ap-hop-paris.fr
authors.forename: M
authors.initials: M
authors.lastname: Houang
authors.forename: M
authors.initials: M
authors.lastname: Gourmelen
authors.forename: L
authors.initials: L
authors.lastname: Moatti
authors.forename: Bouc Y
authors.initials: BY
authors.lastname: Le
authors.forename: E N
authors.initials: EN
authors.lastname: Garabédian
authors.forename: F
authors.initials: F
authors.lastname: Denoyelle
mesh_terms: D000293:Adolescent; D001827:Body Height; D000072259:Connexin 26; D017630:Connexins / Q000235:genetics* / Q000502:physiology; D003638:Deafness / Q000235:genetics*; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone; D006130:Growth Disorders / Q000235:genetics; D006720:Homozygote; D006801:Humans; D007006:Hypogonadism / Q000235:genetics*; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D009154:Mutation; D011627:Puberty; D011628:Puberty, Delayed / Q000235:genetics; D013739:Testosterone / Q000097:blood / Q000627:therapeutic use
chemical_list: D017630:Connexins; C000607042:GJB2 protein, human; D000072259:Connexin 26; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone